Migraine is a neuronal disease

Journal of Neural Transmission

Volumn 118, Issue 4, 2011, Pages 511-524

  Tajti, J ^a   Pardutz A ^a   Vamos E ^b   Tuka, B ^a   Kuris, A ^a   Bohar Zs ^a   Fejes, A ^a   Toldi, J ^b   Vecsei L ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Calcitonin gene related peptide; Cortical spreading depression; Glutamate; Kynurenic acid; Migraine; Trigeminal system

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; ANTICONVULSIVE AGENT; DIZOCILPINE; GLUTAMIC ACID; KYNURENINE; TEZAMPANEL; TRIPTAN DERIVATIVE;

BLOOD BRAIN BARRIER; CLINICAL FEATURE; DEPRESSION; DRUG MECHANISM; HUMAN; MIGRAINE; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; TRIGEMINAL NERVE;

ANIMALS; BRAIN STEM; CALCITONIN GENE-RELATED PEPTIDE; CEREBRAL CORTEX; CORTICAL SPREADING DEPRESSION; GLUTAMIC ACID; HUMANS; KYNURENIC ACID; MIGRAINE DISORDERS; NERVE NET; PERIAQUEDUCTAL GRAY; TRIGEMINAL NERVE; TRIGEMINAL NUCLEI;

EID: 79956193371     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-010-0515-3     Document Type: Review

References (223)

1. Abbracchio MP, Burnstock G, Verkhratsky A, Zimmermann H (2009) Purinergic signalling in the nervous system: an overview. Trends Neurosci 32:19-29
2. Akerman S, Goadsby PJ (2005) Topiramate inhibits cortical spreading depression in rat and cat: impact in migraine aura. Neuroreport 16:1383-1387 (Pubitemid 41225215)
3. Alkondon M, Pereira EF, Yu P (2004) Targeted deletion of the kynurenine aminotransferase ii gene reveals a critical role of endogenous kynurenic acid in the regulation of synaptic transmission via alpha7 nicotinic receptors in the hippocampus. J Neurosci 24:4635-4648 (Pubitemid 38656619)
4. Amara SG, Jonas V, Rosenfeld MG, Ong ES, Evans RM (1982) Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 298:240-244 (Pubitemid 12089405)
5. Anthony M, Hinterberger H, Lance JW (1969) The possible relationship of serotonin of the migraine syndrome. Res Clin Stud Headache 2:29-59
6. Anzai M, Suzuki Y, Takayasu M (1995) Vasorelaxant effect of PACAP-27 on canine cerebral arteries and rat intracerebral arterioles. Eur J Pharmacol 285:173-179
7. Arulmani U, Maassenvandenbrink A, Villalon CM, Saxena PR (2004) Calcitonin gene-related peptide and its role in migraine pathophysiology. Eur J Pharmacol 500:315-330 (Pubitemid 39304018)
8. Aurora SK (2009) Is chronic migraine one end of a spectrum of migraine or a separate entity? Cephalalgia 29:597-605
9. Ayata C, Jin H, Kudo C, Dalkara T, Moskowitz MA (2006) Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol 59:652-661
10. Bartsch T, Goadsby PJ (2002) Stimulation of the greater occipital nerve induces increased central excitability of dural afferent input. Brain 125:1496-1509 (Pubitemid 34755165)
11. Bartsch T, Goadsby PJ (2003) Increased responses in trigeminocervical nociceptive neurons to cervical input after stimulation of the dura mater. Brain 126:1801-1813 (Pubitemid 36917339)
12. Bartsch T, Goadsby PJ (2005) Anatomy and physiology of pain referral patterns in primary and cervicogenic headache disorders. Headache Curr 2:42-48 (Pubitemid 41702573)
13. Bartsch T, Knight YE, Goadsby PJ (2004) Activation of 5-HT(1B/1D) receptor in the periqueductal gray inhibits nociception. Ann Neurol 56:371-381 (Pubitemid 39166556)
14. Basarsky TA, Duffy SN, Andrew RD, MacVicar BA (1998) Imaging spreading depression and associated intracellular calcium waves in brain slices. J Neurosci 18:7189-7199 (Pubitemid 28425806)
15. Basarsky TA, Feighan D, MacVicar BA (1999) Glutamate release through volume-activated channels during spreading depression. J Neurosci 19:6439-6445 (Pubitemid 29347443)
16. Basbaum AJ, Clanton CH, Fields HL (1978) Three bulbospinal pathways from the rostral medulla of the cat: an autoradiographic study of pain-modulating systems. J Comp Neurol 178:209-224 (Pubitemid 8373123)
17. Bates E, Nikai T, Brennan K, Fu YH, Charles A, Basbaum A, Ptáček L, Ahn A (2009) Sumatriptan alleviates nitroglycerin- induced mechanical and thermal allodynia in mice. Cephalalgia. doi: 10.1111/j.1468-2982.2009.01864
18. Behbehani MM, Fields HL (1979) Evidence that an excitatory connection between periaqueductal gray and the nucleus raphe magnus mediates stimulation-produced analgesia. Brain Res 170:85-93 (Pubitemid 9215034)
19. Bereiter DA, Bereiter DF, Hathaway CB (1996) The NMDA receptor antagonist MK-801 reduces Fos-like immunoreactivity in central trigeminal neurons and blocks select endocrine and autonomic responses to corneal stimulation in the rat. Pain 64:179-189 (Pubitemid 26062254)
20. Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ (2002) New migraine preventive options: an update with pathophysiological considerations. Rev Hosp Clin Fac Med Sao Paulo 54:293-298
21. Bigal ME, Rapoport A, Sheftell F, Tepper E, Tepper SJ (2008) Memantine in the preventive treatment of refractory migraine. Headache 48:1337-1342
22. Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA, Moskowitz MA (2002) Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 8:136-142 (Pubitemid 34155124)
23. Bölcskei H, Farkas B, Kocsis P, Tarnawa I (2009) Recent advancements in anti-migraine drug research: focus on attempts to decrease neuronal hyperexcitability. Recent Pat CNS Drug Discov 4:14-36
24. Bowyer SM, Aurora KS, Moran JE, Tepley N, Welch KM (2001) Magnetoencephalographic fields from patients with spontaneous and induced migraine aura. Ann Neurol 50:582-587 (Pubitemid 33021915)
25. Burstein R, Cutrer FM, Yarnitsky D (2000a) The development of cutaneous allodynia during a migraine attack: clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain 123:1703-1709 (Pubitemid 30481193)
26. Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH (2000b) An association between migraine and cutaneous allodynia. Ann Neurol 47:614-624 (Pubitemid 30261897)
27. Busija DW, Bari F, Domoki F, Horiguchi T, Shimizu K (2008) Mechanisms involved in the cerebrovascular dilator effects of cortical spreading depression. Prog Neurobiol 86:417-433
28. Cabral-Filho JE, Trindade-Filho EM, Guedes RC (1995) Effect of d-fenfluramine on cortical spreading depression in rats. Braz J Med Biol Res 28:347-350
29. Canals S, Makarova I, Lopez-Aguado L, Largo C, Ibarz JM, Herreras O (2005) Longitudinal depolarization gradients along the somatodendritic axis of CA1 pyramidal cells: a novel feature of spreading depression. J Neurophysiol 94:943-951 (Pubitemid 41061335)
30. Cardell LO, Uddman R, Sundler F (1991) Pituitary adenylate cyclase activating peptide (PACAP) in guinea-pig lung: distribution and dilatory effects. Regul Pept 36:379-389
31. Charles A (1998) Intercellular calcium waves in glia. Glia 24:39-49
32. Charles A (2007) Links between cortical spreading depression and migraine pain. Cephalalgia 27:575-576
33. Chen G, Gao W, Reinert KC, Popa LS, Hendrix CM, Ross ME, Ebner TJ (2005) Involvement of Kv1 potassium channels in spreading acidification and depression in the cerebellar cortex. J Neurophysiol 94:1287-1298 (Pubitemid 41061365)
34. Chuquet J, Hollender L, Nimchinsky E (2007) High-resolution in vivo imaging of the neurovascular unit during spreading depression. J Neurosci 27:4036-4044 (Pubitemid 46597148)
35. Classey JD, Knight YE, Goadsby PJ (2001) The NMDA receptor antagonist MK-801 reduces Fos-like immunoreactivity within the trigeminocervicalis complex following superior sagittal sinus stimulation in the cat. Brain Res 907:117-124 (Pubitemid 32595518)
36. Cropper EC, Eisenman JS, Azmitis EC (1984) 5-HT-immunoreactive fibers in the trigeminal nuclear complex of the rat. Exp Brain Res 55:515-522 (Pubitemid 14085206)
37. Cunningham RF, Israili ZH, Dayton PG (1981) Clinical pharmacokinetics of probenecid. Clin Pharmacokinet 6:135-151 (Pubitemid 12164164)
38. Davidoff RA (1995) Migraine: manifestations, pathogenesis and management. Davis Co, Philadelphia, pp 115-180
39. + pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 33:192-196
40. de Tommaso M, Libro G, Guido M, Difruscolo O, Losito L, Sardaro M, Cerbo R (2004) Nitroglycerin induces migraine headache and central sensitization phenomena in patients with migraine without aura: a study of laser evoked potentials. Neurosci Lett 363:272-275 (Pubitemid 38746527)
41. Dichgans M, Freilinger T, Eckstein G, Babini E, Lorenz-Depiereux B, Biskup S, Ferrari MD, Herzog J, van den Maagdenberg AM, Pusch M, Strom TM (2005) Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 366:371-377 (Pubitemid 41073954)
42. Dickinson L, Aramori I, McCulloch J, Sharkey J, Finlayson K (2006) A systematic comparison of intracellular cyclic AMP and calcium signalling highlights complexities in human VPAC/PAC receptor pharmacology. Neuropharmacology 51:1086-1098 (Pubitemid 44767583)
43. Diener HC (1997) Positron emission tomography studies in headache. Headache 37:622-625
44. Diener HC (1999) How can PET scans help us understand headache mechanisms? Cephalalgia 23:15-18
45. Diener HC, May A (1996) Positron emission tomography studies in acute migraine attacks. In: Sandler M, Ferrari M, Harnett S (eds) Migraine: pharmacology, genetics. Chapman and Hall, London, pp 109-116
46. Dodick D, Silberstein S (2006) Central sensitization theory of migraine: clinical implications. Headache 46:S182-S191 (Pubitemid 44656903)
47. dos Santos AA, Pinheiro PC, de Lima DS, Ozias MG, de Oliveira MB, Guimarães NX, Guedes RC (2006) Fluoxetine inhibits cortical spreading depression in weaned and adult rats suckled under favorable and unfavorable lactation conditions. Exp Neurol 200:275-282
48. Dreier JP, Woitzik J, Fabricius M, Bhatia R, Major S, Drenckhahn C, Lehmann TN, Sarrafzadeh A, Willumsen L, Hartings JA, Sakowitz OW, Seemann JH, Thieme A, Lauritzen M, Strong AJ (2006) Delayed ischaemic neurological deficits after subarachnoid haemorrhage are associated with clusters of spreading depolarizations. Brain 129:3224-3237 (Pubitemid 44871438)
49. Edelmayer RM, Vanderah TW, Majuta L, Zhang ET, Fioravanti B, Felice M, Chichorro JG, Ossipov MH, King T, Lai J, Kori SH, Nelsen AC, Cannon KE, Heinricher MM, Porreca F (2009) Medullary pain facilitating neurons mediate allodynia in headache-related pain. Ann Neurol 65:184-193
50. Edvinsson L (2003) New therapeutic target in primary headaches - blocking the CGRP receptor. Expert Opin Ther Targets 7:377-383
51. Edvinsson L (2006) Neuronal signal substances as biomarkers of migraine. Headache 46:1088-1094
52. Edvinsson L (2008a) CGRP blockers in migraine therapy: where do they act? Br J Pharmacol 155:967-969
53. Edvinsson L (2008b) CGRP-receptor antagonism in migraine treatment. Lancet 372:2089-2090
54. Edvinsson L, Goadsby PJ (1995) Neuropeptides in the cerebral circulation: relevance to headache. Cephalalgia 15:272-276
55. Edvinsson L, Uddman R (1981) Adrenergic, cholinergic and peptidergic nerve fibers in dura mater-involvement in headache? Cephalalgia 1:175-179
56. Edvinsson L, Uddman R (2005) Neurobiology in primary headaches. Brain Res Rev 48:438-456 (Pubitemid 40731510)
57. Eikermann-Haerter K, Dilekoz E, Kudo C, Savitz SI, Waeber C, Baum MJ, Ferrari MD, van den Maagdenberg AM, Moskowitz MA, Ayata C (2009) Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1. J Clin Invest 119:99-109
58. Entrena A, Camacho ME, Carrion MD, Lopez-Cara LC, Velasco G, Leon J, Escames G, cuna-Castroviejo D, Tapias V, Gallo MA, Vivo A, Espinosa A (2005) Kynurenamines as neural nitric oxide synthase inhibitors. J Med Chem 48:8174-8181
59. Fabricius M, Jensen LH, Lauritzen M (1993) Microdialysis of interstitial amino acids during spreading depression and anoxic depolarization in rat neocortex. Brain Res 612:61-69 (Pubitemid 23167263)
60. Faria LC, Mody I (2004) Protective effect of ifenprodil against spreading depression in the mouse entorhinal cortex. J Neurophysiol 92:2610-2614
61. Ferrari MD, Odink J, Tapparelli C, van Kempen GMJ, Pennings EJM, Bruyn GW (1989) Serotonin metabolism in migraine. Neurology 39:1239-1242 (Pubitemid 19239731)
62. Ferrari A, Spaccapelo L, Pinetti D, Tacchi R, Bertolini A (2009) Effective prophylactic treatments of migraine lower plasma glutamate levels. Cephalalgia 29:423-429
63. Fields HL, Basbaum AI (1999) Central nervous system mechanisms of pain modulation. In: Wall PED, Melzack R (eds) Textbook of pain. Churchill Livingstone, Edinburgh
64. Fishman P, Black L (1999) Indirect costs of migraine in a managed care population. Cephalalgia 19:50-57 (Pubitemid 29136852)
65. Fricke B, Andres KH, Von During M (2001) Nerve fibers innervating the cranial and spinal meninges: morphology of nerve fiber terminals and their structural integration. Microsc Res Tech 53:96-105 (Pubitemid 32378041)
66. Fukui S, Schwarcz R, Rapoport SI, Takada Y, Smith QR (1991) Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism. J Neurochem 56:2007-2017
67. Garry MG, Walton LP, Davis MA (2000) Capsaicin-evoked release of immunoreactive calcitonin gene-related peptide from the spinal cord is mediated by nitric oxide but not by cyclic GMP. Brain Res 861:208-219 (Pubitemid 30173307)
68. Gerth WC, Carides GW, Dasbach EJ, Visser WH, Santanello NC (2001) The multinational impact of migraine symptoms on healthcare utilisation and work loss. Pharmacoeconomics 19:197-206 (Pubitemid 32176472)
69. Goadsby PJ (1998) A triptan too far? J Neurol Neurosurg Psychol 64:143-147
70. Goadsby PJ (2001) Migraine, aura, and cortical spreading depression: why are we still talking about it? Ann Neurol 49:4-6
71. Goadsby PJ (2005) Migraine, allodynia, sensitisation and all of that. Eur Neurol 53:10-16
72. Goadsby PJ (2007) Recent advances in understanding migraine mechanisms, molecules and therapeutics. Trends Mol Med 13:39-44
73. Goadsby PJ, Classey JD (2000) Glutamatergic transmission in the trigeminal nucleus assessed with local blood flow. Brain Res 875:119-124
74. Goadsby PJ, Edvinsson L (1993) The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 33:48-56 (Pubitemid 23009909)
75. Goadsby PJ, Edvinsson L, Ekman R (1988) Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol 23:193-196 (Pubitemid 18081459)
76. Goadsby PJ, Edvinsson L, Ekman R (1990) Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 18:183-187 (Pubitemid 20244522)
77. Goadsby PJ, Lipton RB, Ferrari MD (2002) Migraine-current understanding and treatment. N Engl J Med 346:257-270
78. Goadsby PJ, Charbit AR, Andreou AP, Akerman S, Holland PR (2009a) Neurobiology of migraine. Neuroscience 161:327-341
79. Goadsby PJ, Ferrari MD, Csanyi A, Olesen J, Mills JG (2009b) Tonabersat TON-01-05 Study Group. Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis. Cephalalgia 7:742-750
80. Gulbenkian S, Uddman R, Edvinsson L (2001) Neuronal messengers in the human cerebral circulation. Peptides 22:995-1007 (Pubitemid 32522976)
81. Gursoy-Ozdemir Y, Qiu J, Matsuoka N, Bolay H, Bermpohl D, Jin H, Wang X, Rosenberg GA, Lo EH, Moskowitz MA (2004) Cortical spreading depression activates and upregulates MMP-9. J Clin Invest 113:1447-1455 (Pubitemid 39071700)
82. Hadjikhani N, Sanchez Del Rio M, Wu O, Schwartz D, Bakker D, Fischl B, Kwong KK, Cutrer FM, Rosen BR, Tootell RB, Sorensen AG, Moskowitz MA (2001) Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA 98:4687-4692 (Pubitemid 32295037)
83. Haley JE, Sullivan AF, Dickenson AH (1990) Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat. Brain Res 518:218-226 (Pubitemid 20197052)
84. Hardingham GE, Bading H (2003) The Yin and Yang of NMDA receptor signalling. Trends Neurosci 26:81-89 (Pubitemid 36110542)
85. Hasbak P, Opgaard OS, Eskesen K, Schifter S, Arendrup H, Longmore J, Edvinsson L (2003) Investigation of CGRP receptors and peptide pharmacology in human coronary arteries. Characterization with a nonpeptide antagonist. J Pharmacol Exp Ther 304:326-333 (Pubitemid 36008945)
86. Haydon PG, Carmignoto G (2006) Astrocyte control of synaptic transmission and neurovascular coupling. Physiol Rev 86:1009-1031 (Pubitemid 44033387)
87. Headache Classification Committee of the International Headache Society (2004) The International Classification of Headache Disorders. Cephalalgia 24:1-160
88. Henning EC, Meng X, Fisher M, Sotak CH (2005) Visualization of cortical spreading depression using manganese-enhanced magnetic resonance imaging. Magn Reson Med 53:851-857 (Pubitemid 40478434)
89. Hill RG, Salt TE (1982) An ionophoretic study of the responses of rat caudal trigeminal nucleus neurones to non-noxious mechanical sensory stimuli. J Physiol 327:65-78 (Pubitemid 12086439)
90. Hilmas C, Pereira EF, Alkondon M, Rassoulpour A, Schwarcz R, Albuquerque EX (2001) The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J Neurosci 21:7463-7473 (Pubitemid 32904945)
91. Ho TW, Mannix LK, Pan X, Assaid C, Furtek C, Jones CJ, Lines CR, Rapoport AM (2008) Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. Neurology 70:1304-1312 (Pubitemid 351550355)
92. Ingram SL, Williams JT (1996) Modulation of the hyperpolarizationactivated current (Ih) by cyclic nucleotides in guinea-pig primary afferent neurons. J Physiol 492:97-106
93. Iversen HK, Olesen J (1996) Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for development of migraine drugs. Cephalalgia 16:412-418
94. Jensen R (2000) Central and peripheral mechanisms in migraine: a neurophysiological approach. Funct Neurol 15:63-67
95. Jeong HJ, Chenu D, Johnson EE, Connor M, Vaughan CW (2008) Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey. Mol Pain 4:54
96. Juhász G, Zsombok T, Modos EA, Olajos S, Jakab B, Németh J, Szolcsányi J, Vitrai J, Bagdy G (2003) NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release. Pain 106:461-470 (Pubitemid 37505895)
97. Juhász G, Zsombok T, Jakab B, Németh J, Szolcsányi J, Bagdy G (2005) Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack. Cephalalgia 25:179-183 (Pubitemid 40321709)
98. Kaube H, Goadsby PJ (1994) Anti-migraine compounds fail to modulate the propagation of cortical spreading depression in the cat. Eur Neurol 34:30-35 (Pubitemid 24014718)
99. Keller JT, Marfurt CF (1991) Peptidergic and serotonergic innervation of rat dura mater. J Comp Neurol 309:515-534
100. Kelman L (2004) The aura: a tertiary care study of 952 migraine patients. Cephalalgia 24:728-734
101. Kerr FWL, Olafson RA (1961) Trigeminal and cervical volleys. Arch Neurol 5:69-76
102. Kessler M, Terramani T, Lynch G, Baudry M (1989) A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists. J Neurochem 52:1319-1328 (Pubitemid 19085960)
103. Knight YE, Goadsby PJ (2001) The periaqueductal gray matter modulates trigeminovascular input: a role in migraine? Neuroscience 106:793-800
104. Knight YE, Bartsch T, Kaube H, Goadsby PJ (2002) P/Q-type calcium-channel blockade in the periaqueductal gray facilitates trigeminal nociception: a functional genetic link for migraine? J Neurosci 22:RC213
105. Knyihar-Csillik E, Mihaly A, Krisztin-Peva B, Robotka H, Szatmari I, Fulop F, Toldi J, Csillik B, Vecsei L (2008) The kynurenate analog SZR-72 prevents the nitroglycerol-induced increase of c-fos immunoreactivity in the rat caudal trigeminal nucleus: comparative studies of the effects of SZR-72 and kynurenic acid. Neurosci Res 61:429-432
106. Knyihár-Csillik E, Tajti J, Samsam M, Sáry Gy, Vécsei L (1995) Electrical stimulation of the Gasserian ganglion induces structural alterations of calcitonin gene-related peptide-immunoreactive perivascular sensory nerve terminals in the rat cerebral dura mater: a possible model of migraine headache. Neurosci Lett 184:189-192
107. Knyihár-Csillik E, Chadaide Z, Okuno E, Krisztin-Péva B, Toldi J, Varga C, Molnár A, Csillik B, Vécsei L (2004) Kynurenine aminotransferase in the supratentorial dura mater of the rat: effect of stimulation of the trigeminal ganglion. Exp Neurol 186:242-247
108. Knyihár-Csillik E, Toldi J, Krisztin-Péva B, Chadaide Z, Németh H, Fenyo R, Vécsei L (2007a) Prevention of electrical stimulation-induced increase of c-fos immunoreaction in the caudal trigeminal nucleus by knyurenine combined with probenecid. Neurosci Lett 418:122-126
109. Knyihár-Csillik E, Toldi J, Mihály A, Krisztin-Péva B, Chadaide Z, Németh H, Fenyo R, Vécsei L (2007b) Kynurenine in combination with probenecid mitigates the stimulation-induced increase of c-fos immunoreactivity of the rat caudal trigeminal nucleus in an experimental migraine model. J Neural Transm 114:417-421
110. Kolaj M, Cerne R, Cheng G, Brickey DA, Randić M (1994) Alpha subunit of calcium/calmodulin-dependent protein kinase enhances excitatory amino acid and synaptic responses of rat spinal dorsal horn neurons. J Neurophysiol 72:2525-2531 (Pubitemid 24362643)
111. Kovács K, Kapócs G, Widerlöv E, Ekman R, Vécsei L, Jelencsik I, Csanda E (1991) Suboccipital cerebrospinal fluid and plasma concentrations of corticotropin-releasing hormone and calcitonin gene-related peptide in patients with common migraine. Nord Psykiatr Tidsskr 45:11-16
112. Kunkler PE, Kraig RP (2003) Hippocampal spreading depression bilaterally activates the caudal trigeminal nucleus in rodents. Hippocampus 13:835-844 (Pubitemid 37407970)
113. + rise in hippocampal organ culture. Hippocampus 14:356-367
114. Lambert GA, Zagami AS (2009) The mode of action of migraine triggers: a hypothesis. Headache 49:253-275
115. Lance JW, Lambert GA, Goadsby PJ, Duckworth JW (1983) Brain stem influences on the cephalic circulation: experimental data from cat and monkey of relevance to the mechanism of migraine. Headache 23:258-265 (Pubitemid 14245127)
116. Lance JW, Lambert GA, Goadsby PJ, Zagami AS (1990) Contribution of experimental studies to understanding the pathophysiology of migraine. In: Sandler M, Collins GM (eds) Migraine: a spectrum of ideas. Oxfrod University Press, Oxford, pp 21-39
117. Lashley KS (1941) Patterns of cerebral integration indicated by the scotomas of migraine. Arch Neurol Psychiatry 46:331-339
118. Lassen LH, Ashina M, Christiansen I, Ulrich V, Olesen J (1997) Nitric oxide synthase inhibition in migraine. Lancet 349:401-402 (Pubitemid 27077677)
119. Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B, Olesen J (2002) CGRP may play a causative role in migraine. Cephalalgia 22:54-61 (Pubitemid 34626025)
120. Lassen LH, Jacobsen VB, Haderslev PA, Sperling B, Iversen HK, Olesen J, Tfelt-Hansen P (2008) Involvement of calcitonin gene-related peptide in migraine: regional cerebral blood flow and blood flow velocity in migraine patients. J Headache Pain 9:151-157
121. Lauritzen M (1994) Pathophysiology of the migraine aura leading depression theory. Brain 117:199-210
122. Lauritzen M, Hansen A (1992) The effect of glutamate receptor blockade on anoxic depolarization and cortical spreading depression. J Cereb Blood Flow Metab 12:223-229
123. Leao AAP (1944) Spreading depression of activity in the cerebral cortex. J Neurophysiol 7:391-396
124. Lennerz JK, Ruhle V, Ceppa EP, Neuhuber WL, Bunnet NW, Grady EF (2008) Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. J Comp Neurol 507:1277-1299 (Pubitemid 351413572)
125. Leonardi M, Steiner TJ, Scher AT, Lipton RB (2005) The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, disability and Health (ICF). J Headache Pain 6:429-440 (Pubitemid 43078769)
126. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M (2001) Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 41:646-657 (Pubitemid 32777747)
127. Longoni M, Ferrarese C (2006) Inflammation and excitotoxicity: role in migraine pathogenesis. Neurol Sci 27:S107-S110 (Pubitemid 44390124)
128. Lovick TA, Wolstencroft JH (1983) Projections from brain stem nuclei to the spinal trigeminal nucleus in the cat. Neuroscience 9:411-420 (Pubitemid 13077603)
129. Marchi M, Risso F, Viola C, Cavazzani P, Raiteri M (2002) Direct evidence that release-stimulating alpha7 nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals. J Neurochem 80:1071-1078 (Pubitemid 34809959)
130. Martella G, Costa C, Pisani A, Cupini LM, Bernardi G, Calabresi P (2008) Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine. Cephalalgia 28:1315-1326
131. Martinez F, Castillo J, Rodriguez JR, Leira R, Noya M (1993) Neuroexcitatory amino acid levels in plasma and cerebrospinal fluid during migraine attacks. Cephalalgia 13:89-93 (Pubitemid 23116117)
132. Mayberg M, Langers RS, Zervos NT, Moskowitz MA (1981) Perivascular meningeal projections from cat trigeminal ganglia: possible pathway for vascular headache in man. Science 213:228-230 (Pubitemid 11060572)
133. Menken M, Munsat TL, Toole JF (2000) The global burden of disease study-implications for neurology. Arch Neurol 57:418-420 (Pubitemid 30140537)
134. Messlinger K (2009) Migraine: when and how does the pain originate? Exp Brain Res 196:179-193
135. Mitsikostas DD, Sanchez del Rio M, Waeber C (1998) The NMDA receptor antagonist MK-800 reduces capsaicin induced c-fos expression within rat trigeminal nucleus caudalis. Pain 76:239-248 (Pubitemid 28304962)
136. Miyata A, Arimura A, Dahl RR, Minamino N, Uehara A, Jiang L, Culler MH, Coy DH (1989) Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 164:567-574 (Pubitemid 19269770)
137. Moller K, Zhang YZ, Hakanson R, Luts A, Sjolund B, Uddman R, Sundler F (1993) Pituitary adenylate cyclase activating peptide is a sensory neuropeptide: immunocytochemical and immunochemical evidence. Neuroscience 57:725-732 (Pubitemid 23350559)
138. Morris RG, Panico M, Etienne T, Tippins J, Girgis SI, McIntyre I (1984) Isolation and characterization of human calcitonin gene-related peptide. Nature 308:746-748 (Pubitemid 14127675)
139. Morris RG, Anderson E, Lynch GS, Baudry M (1986) Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 319:774-776 (Pubitemid 16145031)
140. Moskowitz MA (2008) Defining a pathway to discovery from bench to bedside: the trigeminovascular system and sensitization. Headache 48:688-690
141. Moskowitz MA, Nozaki K, Kraig RP (1993) Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms. J Neurosci 13:1167-1177 (Pubitemid 23067603)
142. Moskowitz MA, Bolay H, Dalkara T (2004) Deciphering migraine mechanisms: clues from familial hemiplegic migraine genotypes. Ann Neurol 55:276-280 (Pubitemid 38167005)
143. Obrenovitch TP, Urenjak J, Wang M (2002) Nitric oxide formation during cortical spreading depression is critical for rapid subsequent recovery of ionic homeostasis. J Cereb Blood Flow Metab 22:680-688 (Pubitemid 34596460)
144. Ogi K, Kimura C, Onda H, Arimura A, Fujino M (1990) Molecular cloning and characterization of cDNA for the precursor of rat pituitary adenylate cyclase activating polypeptide (PACAP). Biochem Biophys Res Commun 173:1271-1279
145. Ohkubo S, Kimura C, Ogi K, Okazaki K, Hosoya M, Onda H, Miyata A, Arimura A, Fujino M (1992) Primary structure and characterization of the precursor to human pituitary adenylate cyclase activating polypeptide. DNA Cell Biol 11:21-30
146. Olesen J, Saxena PR (1992) 5-Hydroxytryptamine mechanisms in primary headaches. Raven Press, New York
147. Olesen J, Thomsen LL, Lassen LH, Olesen IJ (1995) The nitric oxide hypothesis of migraine and other vascular headaches. Cephalalgia 15:94-100
148. Olesen J, Diener HC, Husstedt IW, Goadsby PJ, Hall D, Meier U, Pollentier S, Lesko LM (2004) Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 350:1104-1110 (Pubitemid 38298990)
149. Olesen J, Burstein R, Ashina M, Tfelt-Hansen P (2009) Origin of pain in migraine: evidence for peripheral sensitisation. Lancet Neurol 8:679-690
150. 2+ channel gene CACNL1A4. Cell 87:543-552
151. Oshinsky ML, Luo J (2006) Neurochemistry of trigeminal activation in an animal model of migraine. Headache 46:S39-S44 (Pubitemid 43794788)
152. Palkovits M, Jacobowitz DM (1974) Topographic atlas of catecholamine and acetylcholinesterase-containing neurons in the rat brain. II. Hindbrain (mesencephalon, rhombencephalon). J Comp Neurol 157:29-42
153. Panconesi A, Bartoozzi ML, Guidi L (2009) Migraine pain: reflections against vasodilatation. J Headache Pain 10:317-325
154. Pardutz A, Krizbai I, Multon S, Vecsei L, Schoenen J (2000) Systemic nitroglycerin increases nNOS levels in rat trigeminal nucleus caudalis. Neuroreport 11:3071-3075
155. Pardutz A, Multon S, Malgrange B, Parducz A, Vécsei L, Schoenen J (2002) Effect of systemic nitroglycerin on CGRP and 5-HT afferents to rat caudal spinal trigeminal nucleus and its modulation by estrogen. Eur J Neurosci 15:1803-1809 (Pubitemid 35471905)
156. Pardutz A, Szatmári E, Vécsei L, Schoenen J (2004) Nitroglycerin-induced nNOS increase in rat trigeminal nucleus caudalis is inhibited by systemic administration of lysine acetylsalicylate but not of sumatriptan. Cephalalgia 24:439-445 (Pubitemid 38748025)
157. Pardutz A, Hoyk Z, Varga H, Vécsei L, Schoenen J (2007) Oestrogen-modulated increase of calmodulin-dependent protein kinase II (CamKII) in rat spinal trigeminal nucleus after systemic nitroglycerin. Cephalalgia 27:46-53 (Pubitemid 46020801)
158. Peeters M, Gunthorpe MJ, Strijbos PJLM, Goldsmith P, Upton N, James MF (2007) Effects of pan- and subtype-selective N-methyl-D-aspartate receptor antagonists on cortical spreading depression in the rat: therapeutic potential for migraine. J Pharmacol Exp Ther 321:564-572 (Pubitemid 46624518)
159. Perkins MN, Stone TW (1982) An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res 247:184-187 (Pubitemid 12028646)
160. Perkins MN, Stone TW (1985) Actions of kynurenic acid and quinolinic acid in the rat hippocampus in vivo. Exp Neurol 88:570-579 (Pubitemid 15027225)
161. 2+ waves and spreading depression in the mouse neocortex. J Neurosci 23:9888-9896
162. Petzold GC, Windmuller O, Haack S, Major S, Buchheim K, Megow D, Gabriel S, Lehmann TN, Drenckhahn C, Peters O, Meierkord H, Heinemann U, Dirnagl U, Dreier JP (2005) Increased extracellular K+ concentration reduces the efficacy of N-methyl-D-aspartate receptor antagonists to block spreading depression-like depolarizations and spreading ischemia. Stroke 36:1270-1277 (Pubitemid 40798750)
163. Pietrobon D, Striessing J (2003) Neurobiology of migraine. Nat Rev Neurosci 4:386-398 (Pubitemid 37280177)
164. Piovesan EJ, Kowacs PA, Oshinsky ML (2003) Convergence of cervical and trigeminal sensory afferents. Curr Pain Headache Rep 7:377-383 (Pubitemid 38915088)
165. Rajda C, Tajti J, Komoróczy R, Seres E, Klivényi P, Vécsei L (1999) Amino acids in the saliva of migraine patients. Headache 39:644-649
166. Raskin NH, Hosobuchi Y, Lamb S (1987) Headache may arise from perturbation of the brain. Headache 27:416-420 (Pubitemid 17148700)
167. Read SJ, Smith MI, Hunter AJ, Upton N, Parsons AA (2000) SB-220453, a potential novel antimigraine agent, inhibits nitric oxide release following induction of cortical spreading depression in the anaesthetized cat. Cephalalgia 20:92-99 (Pubitemid 32269515)
168. Reuter U, Weber JR, Gold L, Arnold G, Wolf T, Dreier J, Lindauer U, Dirnagl U (1998) Perivascular nerves contribute to cortical spreading depression associated hyperemia in rats. Am J Physiol Heart Circ Physiol 274:1979-1987
169. Robotka H, Toldi J, Vécsei L (2008) L-Kynurenine: metabolism and mechanism of neuroprotection. Future Neurol 3:169-188 (Pubitemid 351385961)
170. Rosenfeld MG, Mermod JJ, Amara SG, Swanson LW, Sawchenko PE, Rivier J, Vale WW, Evans RM (1983) Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature 304:129-135 (Pubitemid 13079138)
171. Rózsa E ́ , Robotka H, Vécsei L, Toldi J (2008) The Janus-face kynurenic acid. J Neural Transm 115:1087-1091
172. Sang CN, Ramadan NM, Wallihan RG, Chappell AS, Freitag FG, Smith TR, Silberstein SD, Johnson KW, Phebus LA, Bleakman D, Ornstein PL, Arnold B, Tepper SJ, Vandenhende F (2004) LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraine. Cephalalgia 24:596-602 (Pubitemid 39272960)
173. Santamaria A, Rios C, Solis-Hernandez F, Ordaz-Moreno J, Gonzalez-Reynoso L, Altagracia M, Kravzov J (1996) Systemic D, L-kynurenine and probenecid pretreatment attenuates quinolinic acid-induced neurotoxicity in rats. Neuropharmacology 35:23-28
174. Sas K, Robotka H, Toldi J, Vécsei L (2007) Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. J Neurol Sci 257:221-239 (Pubitemid 46856508)
175. Schock SC, Munyao N, Yakubchyk Y, Sabourin LA, Hakim AM, Ventureyra ECG, Thompson CS (2007) Cortical spreading depression releases ATP into the extracellular space and purinergic receptor activation contributes to the induction of ischemic tolerance. Brain Res 1168:129-138 (Pubitemid 47320630)
176. Schoenen J (1997) Acute migraine therapy: the newer drugs. Curr Opin Neurol 10:237-243
177. Schoenen J, Ambrosini A, Sándor PS, Maertens de Noordhout A (2003) Evoked potentials and transcranial magnetic stimulation in migraine: published data and viewpoint on their pathophysiologic significance. Clin Neurophysiol 114:955-972 (Pubitemid 36694753)
178. Schoonman GG, van der Grond J, Kortmann C, van der Geest RJ, Terwindt GM, Ferrari MD (2008) Migraine headache is not associated with cerebral or meningeal vasodilatation - a 3T magnetic resonance angiography study. Brain 131:2192-2200
179. Schytz HW, Birk S, Wienecke T, Kruuse C, Olesen J, Ashina M (2009) PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain 132:16-25
180. Seki Y, Suzuki Y, Baskaya MB, Kano T, Saito K, Takayasu M, Shibuya M, Sugita K (1995) The effects of pituitary adenylate cyclase activating polypeptide on cerebral arteries and vertebral artery blood flow in anesthetized dogs. Eur J Pharmacol 275:259-266
181. Shimizu K, Bari F, Busija DW (2000) Glibenclamide enhances cortical spreading depression-associated hyperemia in the rat. NeuroReport 11:2103-2106 (Pubitemid 30485543)
182. Sicuteri F, Testi A, Anselmi B (1961) Biochemical investigations in headache: increase in hydroxyindoleacetic acid excretion during migraine attacks. Int Arch Allergy 19:55-58
183. Sicuteri F, Del BE, Poggioni M, Bonazzi A (1987) Unmasking latent dysnociception in healthy subjects. Headache 27:180-185 (Pubitemid 18001961)
184. Silberstein SD, Lipton RB, Goadsby PJ (1998) Headache in clinical practice. Isis Medical Media, Oxford, pp 41-90
185. Silberstein SD, Schoenen J, Göbel H, Diener HC, Elkind AH, Klapper JA, Howard RA (2009) Tonabersat, a gap-junction modulator: efficacy and safety in two randomized, placebo-controlled, dose-ranging studies of acute migraine. Cephalalgia 29:17-27
186. Smith JM, Bradley DP, James MF, Huang CL (2006) Physiological studies of cortical spreading depression. Biol Rev 81:457-481 (Pubitemid 44711866)
187. Somjen GG (2001) Mechanisms of spreading depression and hypoxic spreading depression-like depolarization. Physiol Rev 81:1065-1096
188. Steiner TJ (2005) Lifting the burden: the global campaign to reduce the burden of headache worldwide. J Headache Pain 6:373-377
189. Steiner TJ, Scher AI, Stewart WF, Kolodner K, Liberman J, Lipton RB (2003) The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity. Cephalalgia 23:519-527 (Pubitemid 37114973)
190. Stone TW, Mackay GM, Forrest CM, Clark CJ, Darlington LG (2003) Tryptophan metabolites and brain disorders. Clin Chem Lab Med 41:852-859 (Pubitemid 37010175)
191. Storer RJ, Goadsby PJ (1999) Trigeminovascular nociceptive transmission involves N-methyl-D-aspartate and non-N-methyl-D-aspartate glutamate receptors. Neuroscience 90:1371-1376 (Pubitemid 29170152)
192. Stovner L, Hogen K, Jensen R, Katsarava Z, Lipton R, Scher A (2007) The global burden of headache a documentation of headache prevalence and disability world-wide. Cephalalgia 27:193-210 (Pubitemid 46354128)
193. Supornsilpchai W, Sanguanrangsirikul S, Maneesri S, Srikiatkhachorn A (2006) Serotonin depletion, cortical spreading depression, and trigeminal nociception. Headache 46:34-39
194. Tajti J, Uddman R, Möller S, Sundler F, Edvinsson L (1999) Messenger molecules and receptor mRNA in the human trigeminal ganglion. J Auton Nerv Syst 76:176-183 (Pubitemid 29322040)
195. Tajti J, Uddman R, Edvinsson L (2001) Neuropeptide messengers in the migraine generator region of the human brainstem. Cephalalgia 21:96-101 (Pubitemid 32575471)
196. Tallaksen-Greene SJ, Young AB, Penney JB, Beitz AJ (1992) Excitatory amino acid binding sites in the trigeminal principal sensory and spinal trigeminal nuclei of the rat. Neurosci Lett 141:79-83
197. Tassorelli C, Joseph SA (1995) Systemic nitroglycerin induces Fos immunoreactivity in brainstem and forebrain structures of the rat. Brain Res 682:167-181
198. 1B/1D receptor agonists. Arch Neurol 59:1084-1088
199. Tobiasz C, Nicholson C (1982) Tetrodotoxin resistant propagation and extracellular sodium changes during spreading depression in rat cerebellum. Brain Res 241:329-333 (Pubitemid 12087168)
200. Uddman R, Goadsby PJ, Jansen J, Edvinsson L (1993) PACAP, a VIP-like peptide: immunohistochemical localization and effect upon cat pial arteries and cerebral blood flow. J Cerebral Blood Flow Metab 13:291-297 (Pubitemid 23067464)
201. Uddman R, Tajti J, Hou M, Sundler F, Edvinsson L (2002) Neuropeptide expression in the human trigeminal nucleus caudalis and in the cervical spinal cord C1 and C2. Cephalalgia 22:112-116 (Pubitemid 34494131)
202. Vámos E, Fejes A, Koch J, Tajti J, Fülöp F, Toldi J, Párdutz Á, Vécsei L (2009a) Kynurenate derivative attenuates the nitroglycerin-induced CamKIIa and CGRP expression changes. Headache. doi:10.1111/j.1526-4610.2009.01574.x
203. Vámos E, Párdutz A, Fejes A, Tajti J, Toldi J, Vécsei L (2009b) Modulatory effects of probenecid on the nitroglycerin-induced changes in the rat caudal trigeminal nucleus. Eur J Pharmacol 621:33-37
204. Vámos E, Párdutz A, Varga H, Bohár Z, Tajti J, Fülöp F, Toldi J, Vécsei L (2009c) L-Kynurenine combined with probenecid and the novel synthetic kynurenic acid derivative attenuate nitroglycerin- induced nNOS in the rat caudal trigeminal nucleus. Neuropharmacology 57:425-429
205. van den Maagdenberg AM, Pietrobon D, Pizzorusso T, Kaja S, Broos LA, Cesetti T, van de Ven RC, Tottene A, van der Kaa J, Plomp JJ, Frants RR, Ferrari MD (2004) A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron 41:701-710 (Pubitemid 38326833)
206. Vanmolkot KR, Kors EE, Turk U, Turkdogan D, Keyser A, Broos LA, Kia SK, van den Heuvel JJ, Black DF, Haan J, Frants RR, Barone V, Ferrari MD, Casari G, Koenderink JB, van den Maagdenberg AM (2006) Two de novo mutations in the Na, K-ATPase gene ATP1A2 associated with pure familial hemiplegic migraine. Eur J Hum Genet 14:555-560
207. Vécsei L (ed) (2005) Kynurenines in the brain. From experiments to clinics. Nova, New York
208. Vécsei L, Miller J, MacGarvey U, Beal MF (1992) Kynurenine and probenecid inhibit pentylenetetrazol- and NMDLA-induced seizures and increase kynurenic acid concentrations in the brain. Brain Res Bull 28:233-238
209. Vikelis M, Mitsikostas DD (2007) The role of glutamate and its receptors in migraine. CNS Neurol Disord Drug Targets 6:251-257 (Pubitemid 47232936)
210. Wahl M, Schilling L, Parsons AA, Kaumann A (1994) Involvement of calcitonin gene-related peptide (CGRP) and nitric oxide (NO) in the pial artery dilatation elicited by cortical spreading depression. Brain Res 637:204-210 (Pubitemid 24061049)
211. Weiller C, May A, Limmorth V, Jüptner M, Kaube H, Schayck R, Coenen HH, Diener HC (1995) Brain stem activation in spontaneous human migraine attacks. Nat Med 1:658-660
212. Welch KM (2005) Brain hyperexcitability: the basis for antiepileptic drugs in migraine prevention. Headache 45:S25-S32
213. Welch KM, Nagesh V, Aurora SK, Gelman N (2001) Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache 41:629-637
214. Wimalawansa SJ (1996) Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology, and therapeutic potentials. Endocr Rev 17:533-585
215. Wolff HG (1963) Headache and other head pain. Oxford University Press, New York
216. Woolf CJ, Salter MW (2000) Neuronal plasticity: increasing the gain in pain. Science 288:1765-1769
217. Woolf CJ, Thompson SW (1991) The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation, implications for the treatment of postinjury pain hypersensitivity states. Pain 44:293-299
218. World Health Organization (2001) The World Health Report 2001. WHO, Geneva
219. Wu Y-J, Boissard CG, Greco C, Gribkoff VK, Harden DG, He H (2003) (S)-N-[1-(3-Morpholin-4-ylphenyl)ethyl]- 3-phenyl-acrylamide: an orally bioavailable KCNQ2 opener with significant activity in a cortical spreading depression model of migraine. J Med Chem 46:3197-3200 (Pubitemid 36842405)
220. Xiong ZQ, Stringer JL (2000) Sodium pump activity, not glial spatial buffering, clears potassium after epileptiform activity induced in the dentate gyrus. J Neurophysiol 83:1443-1451
221. Yokota T (1988) Anatomy and physiology of intra- and extracranial nociceptive afferents and their central projections. In: Olesen J, Edvinsson L (eds) Basic mechanisms of headache. Elsevier, New York
222. Zagami AS, Goadsby PJ, Edvinsson L (1990) Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides. 16:69-75
223. Zagami AS, Edvinsson L, Hoskin KL, Goadsby PJ (1995) Stimulation of the superior sagittal sinus causes extracranial release of PACAP. Cephalalgia 15:109